IGF-1 LR3 is a synthetic, recombinant analog of insulin-like growth factor-1 (IGF-1), featuring a 13-amino-acid N-terminal extension and an arginine substitution at position 3. These modifications reduce binding to IGF-binding proteins (IGFBPs), extending its half-life up to 120 times longer than native IGF-1 while enhancing bioavailability and receptor affinity. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation, ideal for in vitro cell culture, muscle physiology, and metabolic research.
Key Scientific
- High-purity IGF-1 LR3 (≥ 98% by HPLC/MS, receptor-grade where specified)
- Verified 83-amino-acid sequence with N-terminal extension (MFPAMPLLSLFVN) and Arg3 substitution
- Lyophilized formulation for enhanced long-term stability
- Full Certificate of Analysis (COA) included with every batch (HPLC, MS, amino acid analysis)
- Manufactured in a controlled, GMP-aligned facility
- Ideal for cell proliferation, myogenesis, and IGF-1 receptor signaling studies
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- Promotes cell division, hypertrophy, and differentiation in muscle, bone, and connective tissues
- Enhances fat metabolism and inhibits myostatin for potential muscle repair models
- Supports glucose, fatty acid, and amino acid uptake in metabolic and growth studies
- Extended half-life enables sustained IGF-1R activation and reduced IGFBP interference
- Valuable in lactation, neuroprotection, and large-scale biopharmaceutical cell culture
- Reliable batch purity, supporting reproducible outcomes in IGF pathway investigations
Why Researchers Choose Nationwide Peptides
- Receptor-grade potency for maximal in vitro activity (stronger IGF-1R affinity than media-grade)
- Consistent N-terminal modification and low IGFBP binding for reliable assays
- Transparent documentation and third-party analytical reporting
- Trusted by academic, biotechnology, and endocrinology laboratories

